Diagnostics Pipeline: More AI-Reliant Platforms Being Approved by the FDA
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
As technology advances and testing demand grows, automation and AI are increasingly making their way into the clinical lab.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.